AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis
Filed with ASX · · 3 pages · English
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Positive results from Avechos Phase I trial of CBD soft-gel
- September 2021 Quarterly Activities Report & Appendix 4C
- Topical CBD pain study with Lambert Initiative approved
- Dosing begins in Phase I PK trial testing CBD soft-gel
- Phase I clinical trial testing CBD product-enrolment begins
Later from Avecho Biotechnology
- Application for quotation of securities - AVE
- December 2021 Quarterly Activities Report & Appendix 4C
- AVE license agreement for US recreational cannabis market
- Appendix 4E and Annual Report 31 December 2021
- Dosing begins in topical CBD pain study
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology